Heart Failure Pharmacology Flashcards

1
Q

What are the stages of heart failure

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the staples of HF therapy

A

Diuretics + salt/fluid restriction AND

ACE/ARB + BB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are ARNIs and effect

A

Angiotensin Receptor Blocker/Neprilysin Inhibitor

More Natriuretic Peptide effect (more vasodilat), Less AT1 effect (less vasoconstriction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Eligibility for ARNI

A

–EF <35%, NYHA II-III

–GFR >30, K <5.0

–SBP >95mmHg

–On stable dose of ACE-I/ARB

  • BEWARE hypotension
  • Do NOT use if h/o angioedema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Aldosterone antagonists and side effects

A

Spironolactone: Old drug, cheap

–Adverse Effects: Hyperkalemia* (increase in deaths seen after widespread use), 10% gynecomastia

•Eplerenone: New drug, expensive, less gynecomastia

–Adverse Effects: Hyperkalemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

BB shown to have mortality benefit in HFrEF, what is the benefit

A

Metoprolol XL (succinate), Carvedilol, Bisoprolol (Europe)

The beneft of BB is primarly CHRONIC – reduce arrhythmia, protect from adverse effects of chronic adrenergic stimulation, lead to reverse remodeling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Adverse effects of beta blockers

A

Adverse Effects: Hypotension, bradycardia, depression, erectile dysfunction, AV block, bronchospasm (rarely)

CAUTION with dosing in acute decompensated heart failure – the abrupt negative inotropic effects of BB can worsen the decompensation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Effects of ISDN/Hydralazine and adverse effects

A

Vasodilator therapy, causes afterload reduction

Mortality benefit in Black pts who are optimized on BB/ACE-I (A-HeFT study)

Adverse Effects: Headache, dizziness, hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Broad treatment for patient profile. (4 states)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Warm and Wet treatment

A

Diuretics + Afterload Reduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Diuretics used for HF

A

Loop diuretics are staple – use IV at least BID

Thiazide diuretics are add-on therapy if loop diuretics reaching high doses without significant effect (Metalazone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the significance of JVP

A
  • Surrogate measurement for intravascular volume
  • Measuring central venous pressure (CVP), which is surrogate for right atrial pressure (RAP), which can be surrogate for pulmonary capillary wedge pressure (PCWP), which is a surrogate for LV end diastolic pressure (LVEDP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Purpose of afterload reduction in HF

A
  • Heart failure causes activation of the Renin-Angiotensin-Aldosterone system
  • Decreased cardiac output à diminished renal blood flow à activation of RAAS

–ATII increases afterload (vasoconstriction) + Na/H2O retention in kidney

–Aldosterone increases Na/Fluid absorption in kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Approad to beta blockers with HF

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment stapes for cold and wet

A

Diuretics + Afterload Reduction + Inotropes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Actions of inotropes and examples

A

Increase CO by increasing contractility

Adrenergic agents stimulate α/β1 receptors: Dopamine, Dobutamine

PDE 3 inhibitor decreases cAMP degradation à increased intracellular Ca à increased contractility: Milrinone

17
Q

MOA of inotropes

A

Adrenergic agents stimulate the B receptors -> cAMP increase -> increased intracellular calcium -> contraction

PDE3 inhibitors decrease the breakdown of cAMP -> increased intracellular Ca -> contraction

18
Q

Adverse effects of inotropes

A

Dopamine and dobutamine: increase HR and tachychardia

Milrinone: drop in BP, caution in renal failure

19
Q

Effect of nitroprusside

A

Pure afterload reduction (arterial dilation), excellent to reduce afterload (SVR) without changing preload, dropping BP/MAP (sometimes MAP comes up due to decreased SVR so improved CO)

20
Q

MOA of digoxin and effect

A
  • Na+, K+ - ATPase inhibitor
  • Mechanism: Increase intracellular Na+ -> increase Na+/Ca++ exchange -> increase intracellular Ca++ -> increase contractility

•Anti-arrhythmic effect

21
Q

Signs of digoxin toxicity

A
  • Digoxin toxicity: Confusion, nausea/vomitting, diarrhea, bradycardia, ECG findings. Classically associated with yellow vision
  • Suspected toxicity: Check level, check/correct electrolytes, stop digoxin, Digi-bind (Fab antibody) in extreme cases or hyperkalemia (K > 5.5)
22
Q

Drugs that make HFrEF worse

A
23
Q

NON-PHARMACOLOGIC THERAPY
HFrEF

A
  • ICD (Internal Cardiac Defibrillator) to prevent sudden arrhythmic cardiac death
  • CRT (Cardiac Resynchronization Therapy) = Bi-ventricular pacemaker in patients with LBBB
  • Advanced Therapies: Transplant, Ventricular Assist Device (VAD)